Long-Term Oncological Outcomes Related to Lymphadenectomy in Clinical Stage I NSCLC: A Multicenter Retrospective Experience

Background: Lymphadenectomy is considered a key part of the radical treatment of resectable lung cancer, although its appropriate extension in early stages is a debated topic due to the great heterogeneity of studies in the literature. This study aims to evaluate the impact of lymphadenectomy extent...

Full description

Saved in:
Bibliographic Details
Main Authors: Beatrice Manfredini, Carmelina Cristina Zirafa, Alessandro Stefani, Gaetano Romano, Greta Alì, Riccardo Morganti, Ilaria Ceccarelli, Federico Davini, Pier Luigi Filosso, Franca Melfi
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Series:Current Oncology
Subjects:
Online Access:https://www.mdpi.com/1718-7729/32/1/31
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832588739726016512
author Beatrice Manfredini
Carmelina Cristina Zirafa
Alessandro Stefani
Gaetano Romano
Greta Alì
Riccardo Morganti
Ilaria Ceccarelli
Federico Davini
Pier Luigi Filosso
Franca Melfi
author_facet Beatrice Manfredini
Carmelina Cristina Zirafa
Alessandro Stefani
Gaetano Romano
Greta Alì
Riccardo Morganti
Ilaria Ceccarelli
Federico Davini
Pier Luigi Filosso
Franca Melfi
author_sort Beatrice Manfredini
collection DOAJ
description Background: Lymphadenectomy is considered a key part of the radical treatment of resectable lung cancer, although its appropriate extension in early stages is a debated topic due to the great heterogeneity of studies in the literature. This study aims to evaluate the impact of lymphadenectomy extent on survival and recurrence in the treatment of early-stage NSCLC patients undergoing lobectomy and lymph node dissection. Methods: Data from clinical stage I NSCLC patients undergoing lobectomy and hilar-mediastinal lymphadenectomy at two thoracic surgery centers from 2016 to 2019 were retrospectively evaluated. Information regarding perioperative outcomes and lymphadenectomy details was collected and analyzed, and their impact on OS, CSS, and DFS was assessed. Results: During the period under review, 323 patients with stage cI lung cancer underwent lobectomy with lymphadenectomy. Statistical analysis showed that the evaluated lymph nodal factors (mean number of lymph nodes removed and number and type of lymph node station explored) did not statistically significantly impact OS, CSS, and DFS at a median follow-up of 59 months (IQR 45–71). Conclusions: The results of this study suggest that a less invasive procedure than systematic lymphadenectomy could be performed in early-stage cases with adequate preoperative staging.
format Article
id doaj-art-ff16daa1c6164fa2bd5314371d011f3b
institution Kabale University
issn 1198-0052
1718-7729
language English
publishDate 2025-01-01
publisher MDPI AG
record_format Article
series Current Oncology
spelling doaj-art-ff16daa1c6164fa2bd5314371d011f3b2025-01-24T13:28:25ZengMDPI AGCurrent Oncology1198-00521718-77292025-01-013213110.3390/curroncol32010031Long-Term Oncological Outcomes Related to Lymphadenectomy in Clinical Stage I NSCLC: A Multicenter Retrospective ExperienceBeatrice Manfredini0Carmelina Cristina Zirafa1Alessandro Stefani2Gaetano Romano3Greta Alì4Riccardo Morganti5Ilaria Ceccarelli6Federico Davini7Pier Luigi Filosso8Franca Melfi9Minimally Invasive and Robotic Thoracic Surgery, Surgical, Medical, Molecular and Critical Care Pathology Department, University of Pisa, 56126 Pisa, ItalyMinimally Invasive and Robotic Thoracic Surgery, Surgical, Medical, Molecular and Critical Care Pathology Department, University of Pisa, 56126 Pisa, ItalyUnit of Thoracic Surgery, Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, 41121 Modena, ItalyMinimally Invasive and Robotic Thoracic Surgery, Surgical, Medical, Molecular and Critical Care Pathology Department, University of Pisa, 56126 Pisa, ItalyPathological Anatomy, Surgical, Medical, Molecular and Critical Care Pathology Department, University Hospital of Pisa, 56126 Pisa, ItalySection of Statistics, University Hospital of Pisa, 56126 Pisa, ItalyMinimally Invasive and Robotic Thoracic Surgery, Surgical, Medical, Molecular and Critical Care Pathology Department, University of Pisa, 56126 Pisa, ItalyMinimally Invasive and Robotic Thoracic Surgery, Surgical, Medical, Molecular and Critical Care Pathology Department, University of Pisa, 56126 Pisa, ItalyUnit of Thoracic Surgery, Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, 41121 Modena, ItalyUnit of Thoracic Surgery, Department of Pharmacy and Health and Nutrition Sciences, University of Calabria, 87036 Rende, ItalyBackground: Lymphadenectomy is considered a key part of the radical treatment of resectable lung cancer, although its appropriate extension in early stages is a debated topic due to the great heterogeneity of studies in the literature. This study aims to evaluate the impact of lymphadenectomy extent on survival and recurrence in the treatment of early-stage NSCLC patients undergoing lobectomy and lymph node dissection. Methods: Data from clinical stage I NSCLC patients undergoing lobectomy and hilar-mediastinal lymphadenectomy at two thoracic surgery centers from 2016 to 2019 were retrospectively evaluated. Information regarding perioperative outcomes and lymphadenectomy details was collected and analyzed, and their impact on OS, CSS, and DFS was assessed. Results: During the period under review, 323 patients with stage cI lung cancer underwent lobectomy with lymphadenectomy. Statistical analysis showed that the evaluated lymph nodal factors (mean number of lymph nodes removed and number and type of lymph node station explored) did not statistically significantly impact OS, CSS, and DFS at a median follow-up of 59 months (IQR 45–71). Conclusions: The results of this study suggest that a less invasive procedure than systematic lymphadenectomy could be performed in early-stage cases with adequate preoperative staging.https://www.mdpi.com/1718-7729/32/1/31early stageclinical stage INSCLClymphadenectomy
spellingShingle Beatrice Manfredini
Carmelina Cristina Zirafa
Alessandro Stefani
Gaetano Romano
Greta Alì
Riccardo Morganti
Ilaria Ceccarelli
Federico Davini
Pier Luigi Filosso
Franca Melfi
Long-Term Oncological Outcomes Related to Lymphadenectomy in Clinical Stage I NSCLC: A Multicenter Retrospective Experience
Current Oncology
early stage
clinical stage I
NSCLC
lymphadenectomy
title Long-Term Oncological Outcomes Related to Lymphadenectomy in Clinical Stage I NSCLC: A Multicenter Retrospective Experience
title_full Long-Term Oncological Outcomes Related to Lymphadenectomy in Clinical Stage I NSCLC: A Multicenter Retrospective Experience
title_fullStr Long-Term Oncological Outcomes Related to Lymphadenectomy in Clinical Stage I NSCLC: A Multicenter Retrospective Experience
title_full_unstemmed Long-Term Oncological Outcomes Related to Lymphadenectomy in Clinical Stage I NSCLC: A Multicenter Retrospective Experience
title_short Long-Term Oncological Outcomes Related to Lymphadenectomy in Clinical Stage I NSCLC: A Multicenter Retrospective Experience
title_sort long term oncological outcomes related to lymphadenectomy in clinical stage i nsclc a multicenter retrospective experience
topic early stage
clinical stage I
NSCLC
lymphadenectomy
url https://www.mdpi.com/1718-7729/32/1/31
work_keys_str_mv AT beatricemanfredini longtermoncologicaloutcomesrelatedtolymphadenectomyinclinicalstageinsclcamulticenterretrospectiveexperience
AT carmelinacristinazirafa longtermoncologicaloutcomesrelatedtolymphadenectomyinclinicalstageinsclcamulticenterretrospectiveexperience
AT alessandrostefani longtermoncologicaloutcomesrelatedtolymphadenectomyinclinicalstageinsclcamulticenterretrospectiveexperience
AT gaetanoromano longtermoncologicaloutcomesrelatedtolymphadenectomyinclinicalstageinsclcamulticenterretrospectiveexperience
AT gretaali longtermoncologicaloutcomesrelatedtolymphadenectomyinclinicalstageinsclcamulticenterretrospectiveexperience
AT riccardomorganti longtermoncologicaloutcomesrelatedtolymphadenectomyinclinicalstageinsclcamulticenterretrospectiveexperience
AT ilariaceccarelli longtermoncologicaloutcomesrelatedtolymphadenectomyinclinicalstageinsclcamulticenterretrospectiveexperience
AT federicodavini longtermoncologicaloutcomesrelatedtolymphadenectomyinclinicalstageinsclcamulticenterretrospectiveexperience
AT pierluigifilosso longtermoncologicaloutcomesrelatedtolymphadenectomyinclinicalstageinsclcamulticenterretrospectiveexperience
AT francamelfi longtermoncologicaloutcomesrelatedtolymphadenectomyinclinicalstageinsclcamulticenterretrospectiveexperience